Literature DB >> 23798326

Severity and prognostic assessment of the endotoxin activity assay in biliary tract infection.

Mari Sato1, Ryusei Matsuyama, Toshiaki Kadokura, Ryutaro Mori, Takafumi Kumamoto, Kazunori Nojiri, Koichi Taniguchi, Kazuhisa Takeda, Kensuke Kubota, Kuniya Tanaka, Itaru Endo.   

Abstract

BACKGROUND: Acute cholangitis and cholecystitis (AC) often progress to severe septic conditions. We evaluated the endotoxin activity assay (EAA) for assessment and prediction of the severity of AC.
METHODS: We retrospectively reviewed 98 patients diagnosed with AC. We divided them into low (<0.4) and high (≥0.4) groups based on EAA values.
RESULTS: Endotoxin levels showed no correlation with EAA values. Serum C-reactive protein (8.57 vs. 5.23 mg/dl, P = 0.02), procalcitonin (2.45 vs. 0.48 ng/ml, P = 0.004), and the positive culture rate of blood (50% vs. 15%, P < 0.001) were significantly higher in the high group than in the low group. Platelet counts were significantly lower in the high group than in the low group (23.9 vs. 13.5 10(4) /ml, P = 0.004). The ratio of patients with a Japanese Association for Acute Medicine disseminated intravascular coagulation score ≥4 (32% vs. 14%, P = 0.032) was significantly higher in the high group than in the low group. There was a significantly higher percentage of patients with a severe grade of AC in the high group than patients with a mild or moderate grade (32% vs. 15%, P = 0.05).
CONCLUSIONS: Endotoxin activity assay is useful for assessment and early prediction of septic conditions due to AC.
© 2013 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  Cholangitis; Endotoxin; Endotoxin activity assay; Sepsis

Mesh:

Substances:

Year:  2013        PMID: 23798326     DOI: 10.1002/jhbp.10

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  3 in total

1.  Increased Endotoxin Activity Is Associated with the Risk of Developing Acute-on-Chronic Liver Failure.

Authors:  Hiroaki Takaya; Tadashi Namisaki; Shinya Sato; Kosuke Kaji; Yuki Tsuji; Daisuke Kaya; Yukihisa Fujinaga; Yasuhiko Sawada; Naotaka Shimozato; Hideto Kawaratani; Kei Moriya; Takemi Akahane; Akira Mitoro; Hitoshi Yoshiji
Journal:  J Clin Med       Date:  2020-05-14       Impact factor: 4.241

2.  The maximum chemiluminescence intensity predicts severe neutropenia in gemcitabine-treated patients with pancreatic or biliary tract cancer.

Authors:  Koki Goto; Ryusei Matsuyama; Yusuke Suwa; Sayaka Arisaka; Toshiaki Kadokura; Mari Sato; Ryutaro Mori; Takafumi Kumamoto; Masataka Taguri; Itaru Endo
Journal:  Cancer Chemother Pharmacol       Date:  2018-09-14       Impact factor: 3.333

3.  Plasma Procalcitonin Is Useful for Predicting the Severity of Acute Cholecystitis.

Authors:  Saben Sakalar; Engin Ozakın; Arif Alper Cevik; Nurdan Acar; Serkan Dogan; Filiz Baloglu Kaya; Taylan Kara
Journal:  Emerg Med Int       Date:  2020-01-14       Impact factor: 1.112

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.